232 Results for "

glaucoma

" in MedChemExpress (MCE) Product Catalog:
Products (232)

232 Results for "glaucoma" in MCE Product Catalog:

Cat. No.: HY-139419
CAS No.: 1194396-71-8
Purity:  98.34%
Synonyms: NCX 470
Bimatoprost grenod (NCX 470) is a second-generation nitric oxide (NO)-donating prostaglandin analogue. Bimatoprost grenod effectively lowers intraocular pressure (IOP) in animal models of ocular hypertension and glaucoma by activating bimatoprost-mediated uveoscleral outflow and NO mediated conventional outflow. Bimatoprost grenod can be used for the research of cular hypertension and glaucoma .
loading...
    loading...
Cat. No.: HY-14227
CAS No.: 1116571-01-7
Purity:  99.33%
Target:  

LIM Kinase (LIMK) ROCK

Research Areas:  

Others

LIMK-IN-1 (Compound 14) is an inhibitor of LIM-Kinase (LIMK), with IC50s of 0.5 nM and 0.9 nM for LIMK1 and LIMK2, respectively. LIMK-IN-1 can be used for ocular hypertension and associated glaucoma research .
loading...
    loading...
Cat. No.: HY-P10019
CAS No.: 2243292-26-2
Synonyms: NLY01
Target:  

GCGR

Pegsebrenatide (NLY01) is a blood-brain barrier-penetrant GLP-1R agonist. Pegsebrenatide alleviates retinal inflammation and neuronal death secondary to ocular hypertension . Pegsebrenatide significantly delays onset and reduces disease severity in experimental autoimmune encephalomyelitis . Pegsebrenatide inhibits the formation of A1 reactive astrocytes in nerve cells and reduces the loss of retinal ganglion cells and dopaminergic neurons. Pegsebrenatide exerts neuroprotective effects in a mouse model of Parkinson's disease by directly preventing microglia-mediated conversion of astrocytes to the A1 neurotoxic phenotype. Pegsebrenatide can be used for research on glaucoma, Parkinson's disease, and multiple sclerosis .
loading...
    loading...
Cat. No.: HY-106007
CAS No.: 871108-05-3
Purity:  99.97%
Synonyms: INO-8875
Target:  

Adenosine Receptor

Research Areas:  

Inflammation/Immunology

Trabodenoson (INO-8875), an adenosine mimetic, is a highly selective Adenosine A1 receptor agonist. Trabodenoson (INO-8875) is used in the study for Primary Open-Angle Glaucoma .
loading...
    loading...
Cat. No.: HY-135163
CAS No.: 913258-34-1
Synonyms: (5E)-Latanoprost; 5,6-trans-Latanoprost
Research Areas:  

Others

trans-Latanoprost (5,6-trans-Latanoprost) is the trans isomer of Latanoprost (HY-B0577). trans-Latanoprost is promising for research of glaucoma and high eye pressure .
loading...
    loading...
Cat. No.: HY-128538
CAS No.: 1262873-06-2
Synonyms: ONO-9054
Research Areas:  

Neurological Disease

Sepetaprost (ONO-9054) is a dual agonist of the prostaglandin E3 receptor and prostaglandin F receptor. Sepetaprost reduces intraocular pressure in animal models. Sepetaprost is applicable for research on ocular hypertension and open-angle glaucoma .
loading...
    loading...
Cat. No.: HY-113089A
Purity:  98.55%
Synonyms: H-Glu(H-Lys-OH)-OH TFA; γ-Glu-ε-Lys TFA
Epsilon-(gamma-glutamyl)-lysine TFA (H-Glu (H-Lys-OH)-OH) is an isodipeptide formed during the proteolytic degradation of proteins containing Nε-(γ-glutamyl)-lysine cross-links. Epsilon-(gamma-glutamyl)-lysine TFA serves as a substrate for γ-glutamylamine cyclotransferase, which specifically cleaves it. Epsilon-(gamma-glutamyl)-lysine TFA is applicable to studies related to transglutaminase-mediated protein cross-linking and turnover, γ-glutamylamine cyclotransferase activity, glaucoma, and tissue scar formation .
loading...
    loading...
Cat. No.: HY-P99695
CAS No.: 285985-06-0
Synonyms: CAT-152

Target:  

TGF-beta/Smad

Research Areas:  

Neurological Disease

Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research .
loading...
    loading...
Cat. No.: HY-170818
Target:  

HSP

Research Areas:  

Cancer

Grp94 Inhibitor-3 (Compound C6) is a selective glucose regulated protein 94 (Grp94) inhibitor with an affinity of 5.52 μM. Grp94 Inhibitor-3 is promising for research of primary open-angle glaucoma and metastatic cancer .
loading...
    loading...
Cat. No.: HY-B0588A
CAS No.: 150937-43-2
Synonyms: AL-4862 hydrochloride
Target:  

Carbonic Anhydrase

Research Areas:  

Neurological Disease

Brinzolamide (AL-4862) hydrochloride is a selective carbonic anhydrase II inhibitor with an IC50 value of 3.2 nM. Brinzolamide hydrochloride reduces intraocular pressure (IOP) by inhibiting ciliary CA-II and decreasing atrial fluid secretion. Brinzolamide hydrochloride can be used in glaucoma disease research .
loading...
    loading...
Cat. No.: HY-115462
CAS No.: 863704-91-0
Purity:  98.90%
Research Areas:  

Inflammation/Immunology

PGN-9856 is a selective and high affinity (pKi ≥ 8.3) ligand at EP2 receptor. PGN-9856 is a potetn and non-prostanoid EP2 receptor agonist (pEC50 ≥ 8.5). PGN-9856 shows anti-inflammatory and anti-glaucoma activities .
loading...
    loading...
Cat. No.: HY-121166
CAS No.: 93221-48-8
Synonyms: (S)-Betaxolol
Target:  

Adrenergic Receptor

Research Areas:  

Others

Levobetaxolol is a potent and high affinity β-adrenergic antagonist with IC50 values of 33.2, 2970, 709 nM for guinea pig atrial β1, tracheal β2 and rat colonic β3 receptors, respectively. Levobetaxolol reduces IOP (intraocular pressure). Levobetaxolol exhibits a micromolar affinity for L-type Ca21-channels. Levobetaxolol decreases the effects of ischaemia/reperfusion injury in rats. Levobetaxolol has the potential for the research of glaucoma .
loading...
    loading...
Cat. No.: HY-116161A
CAS No.: 130209-76-6
Purity:  99.76%
Research Areas:  

Metabolic Disease

17-Phenyl trinor PGF2α isopropyl ester is a FP receptor agonist and intraocular pressure-lowering agent. 17-Phenyl trinor PGF2α isopropyl ester induces iris sphincter contraction, reduces intraocular pressure and pupil diameter, causes no ocular irritation, and only leads to mild conjunctival hyperemia. 17-Phenyl trinor PGF2α isopropyl ester is applicable to relevant research on glaucoma .
loading...
    loading...
Cat. No.: HY-121398
CAS No.: 52365-63-6
Dipivefrin is a potent adrenergic agonist. Dipivefrin is an adrenergic pro-agent. Dipivefrin can be used for reduce IOP (intraocular pressure) in patients suffering from chronic open angle glaucoma .
loading...
    loading...
Cat. No.: HY-16183
CAS No.: 513-10-0
Synonyms: Echothiophate iodide
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

Echothiopate iodide is a potent hBChE (human butyrylcholinesterase) inhibitor. Echothiopate iodide is a long-acting anticholinesterase agent. Echothiopate iodide can be used for glaucoma research .
loading...
    loading...
Cat. No.: HY-106331A
CAS No.: 126453-94-9
Synonyms: MK-927; (Rac)-MK 417
Target:  

Carbonic Anhydrase

Research Areas:  

Neurological Disease

(Rac)-Sezolamide hydrochloride (MK-927; (Rac)-MK 417) is a carbonic anhydrase inhibitor (CAI) (Ki: 12.0 nM). (Rac)-Sezolamide hydrochloride has a topical intraocular pressure (IOP) lowering effect. (Rac)-Sezolamide hydrochloride can be used in glaucoma research .
loading...
    loading...
Cat. No.: HY-178017
BChE/hCA II-IN-1 (Compound 20) is a dual-functional inhibitor of Butyrylcholinesterase (BChE) and human carbonic anhydrase II (hCA II) with IC50s of 76.50 and 10.69  μM for BChE and hCA II, respectively. BChE/hCA II-IN-1 can be used for neurodegenerative diseases like Alzheimer's and glaucoma research .
loading...
    loading...
Cat. No.: HY-129781
CAS No.: 96803-89-3
Target:  

Carbonic Anhydrase

Research Areas:  

Endocrinology

L-650719 is a topical carbonic anhydrase inhibitor (CAI) with a Ki of 10 nM for CA II. L-650719 has shown good intraocular pressure-lowering effects in a rabbit model. L-650719 may be used in glaucoma research .
loading...
    loading...
Cat. No.: HY-152270
CAS No.: 19825-63-9
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

Pirnabine is a cannabinoid receptor ligand. Pirnabine can be used for the research of glaucoma .
loading...
    loading...
Cat. No.: HY-169137
CAS No.: 90581-63-8
Target:  

Adrenergic Receptor

Research Areas:  

Others

Falintolol is a β-adrenergic receptor antagonist that can be used in glaucoma research .
loading...
    loading...